Publication of Supplementary Prospectus

RNS Number : 8400M
Target Healthcare REIT PLC
18 September 2019
 

TARGET HEALTHCARE REIT PLC        

18 September 2019

LEI: 213800RXPY9WULUSBC04

 

PUBLICATION OF SUPPLEMENTARY PROSPECTUS

Target Healthcare REIT plc (the "Company") has today published a supplementary prospectus approved by the Financial Conduct Authority. The publication of the supplementary prospectus is a regulatory requirement under the Prospectus Regulation Rules following the publication of the Group's Annual Report and Financial Statements for the year ended 30 June 2019.

The supplementary prospectus is supplemental to, and should be read in conjunction with, the prospectus published by the Company on 21 June 2019.

A copy of the supplementary prospectus will shortly be available for inspection at the National Storage Mechanism which is located at http://www.morningstar.co.uk/uk/NSM

The supplementary prospectus is also available in electronic form on the Company's website at www.targethealthcarereit.co.uk and available for collection during normal business hours on any day (Saturday, Sunday and public holidays excepted) until 20 June 2020 at the offices of Dickson Minto W.S., Broadgate Tower, 20 Primrose Street, London EC2A 2EW.

The Company's legal entity identifier: 213800RXPY9WULUSBC04

 

Target Fund Managers Limited



Kenneth MacKenzie


01786 845 912

Gordon Bland


01786 845 920




Stifel Nicolaus Europe Limited



Mark Young

mark.young@stifel.com

+44 20 7710 7600

Neil Winward

neil.winward@stifel.com

+44 20 7710 7600

Tom Yeadon

tom.yeadon@stifel.com

+44 20 7710 7600




FTI Consulting



Dido Laurimore

TargetHealthcare@fticonsulting.com

+44 20 3727 1000

Claire Turvey



Richard Gotla



 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
PSPKMGMLZRRGLZM
UK 100